Anti-GAPDH antibodies have also been detected in patients with schizophrenia and major depression, and administration of these immunoglobulins to mice leads to cognitive and behavioral alterations (Delunardo et al., 2016). This evidence concerns the gene GAPDH and major depressive disorder.